<VariationArchive VariationID="1961244" VariationName="NM_032861.4(SERAC1):c.1266dup (p.Pro423fs)" VariationType="Duplication" Accession="VCV001961244" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2020090" VariationID="1961244">
      <GeneList>
        <Gene Symbol="SERAC1" FullName="serine active site containing 1" GeneID="84947" HGNC_ID="HGNC:21061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158109519" stop="158168262" display_start="158109519" display_stop="158168262" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158530535" stop="158589311" display_start="158530535" display_stop="158589311" Strand="-" />
          </Location>
          <OMIM>614725</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032861.4(SERAC1):c.1266dup (p.Pro423fs)</Name>
      <CanonicalSPDI>NC_000006.12:158119070:TTTTT:TTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158540102" stop="158540103" display_start="158540102" display_stop="158540103" variantLength="1" positionVCF="158540102" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158119070" stop="158119071" display_start="158119070" display_stop="158119071" variantLength="1" positionVCF="158119070" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>P423fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.158540107dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.158540107dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.158119075dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.158119075dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032889.1" sequenceAccession="NG_032889" sequenceVersion="1" change="g.54210dup">
            <Expression>NG_032889.1:g.54210dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.4" sequenceAccession="NM_032861" sequenceVersion="4" change="c.1266dup" MANESelect="true">
            <Expression>NM_032861.4:c.1266dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116250.3" sequenceAccession="NP_116250" sequenceVersion="3" change="p.Pro423fs">
            <Expression>NP_116250.3:p.Pro423fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073096.2" sequenceAccession="NR_073096" sequenceVersion="2" change="n.1276dup">
            <Expression>NR_073096.2:n.1276dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032861.4(SERAC1):c.1266dup (p.Pro423fs) AND 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" Accession="RCV002720597" Version="2">
        <ClassifiedConditionList TraitSetID="8743">
          <ClassifiedCondition DB="MedGen" ID="C4040739">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22683713</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8743" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17318" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ElementValue>
                <XRef ID="MONDO:0013875" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-METHYLGLUTACONIC ACIDURIA, TYPE VI</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEGDEL syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA6</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MEGDEL</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SERAC1 deficiency comprises MEGD(H)EL syndrome (3-methylglutaconic aciduria with deafness-dystonia, [hepatopathy], encephalopathy, and Leigh-like syndrome), juvenile-onset complicated hereditary spastic paraplegia (in 1 consanguineous family), and adult-onset generalized dystonia (in 1 adult male). MEGD(H)EL syndrome is characterized in neonates by hypoglycemia and a sepsis-like clinical picture for which no infectious agent can be found. During the first year of life feeding problems, failure to thrive, and/or truncal hypotonia become evident; many infants experience (transient) liver involvement ranging from undulating transaminases to prolonged hyperbilirubinemia and near-fatal liver failure. By age two years progressive deafness, dystonia, and spasticity prevent further psychomotor development and/or result in loss of acquired skills. Affected children are completely dependent on care for all activities of daily living; speech is absent.</Attribute>
                <XRef ID="NBK195853" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12963" />
                <XRef ID="12963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741715</ID>
                <ID Source="BookShelf">NBK195853</ID>
              </Citation>
              <XRef ID="352328" DB="Orphanet" />
              <XRef ID="C4040739" DB="MedGen" />
              <XRef ID="MONDO:0013875" DB="MONDO" />
              <XRef Type="MIM" ID="614739" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5690062" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="14333919|MedGen:C3553597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003001312" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22683713</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro423Thrfs*5) in the SERAC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERAC1 are known to be pathogenic (PMID: 22683713). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SERAC1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.158540102_158540103insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5690062" TraitType="Disease" MappingType="XRef" MappingValue="C3553597" MappingRef="MedGen">
        <MedGen CUI="C4040739" Name="3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

